Circ-OSBPL2 Contributes to Smoke-Related Chronic Obstructive Pulmonary Disease by Targeting miR-193a-5p/BRD4 Axis

Caifen Zheng1, Yongping Zhang2, Yingchun Zhao3

  • 1Department of Respiratory and Critical Care Medicine, The First People's Hospital of Lianyungang, Lianyungang, People's Republic of China.

Abstract

Insights

Circular RNA oxysterol binding protein like 2 (circOSBPL2) promotes apoptosis, inflammation, and oxidative stress in chronic obstructive pulmonary disease (COPD) by sponging miR-193a-5p, which targets BRD4. This highlights circOSBPL2 as a potential therapeutic target for COPD.

Area of Science:

  • Molecular Biology
  • Respiratory Medicine
  • Genetics

Background:

  • Circular RNAs (circRNAs) are implicated in respiratory diseases.
  • The specific role of circRNA oxysterol binding protein like 2 (circOSBPL2) in smoke-related chronic obstructive pulmonary disease (COPD) requires elucidation.

Purpose of the Study:

  • To investigate the function of circOSBPL2 in the pathogenesis of smoke-related COPD.
  • To explore the molecular mechanisms underlying circOSBPL2's role in COPD development.

Main Methods:

  • Quantified expression of circOSBPL2, miR-193a-5p, and BRD4 using qRT-PCR and Western blot.
  • Utilized cigarette smoke extract (CSE)-induced human bronchial epithelial cells (HBECs) to model COPD in vitro.
  • Assessed cell apoptosis, inflammation (IL-6, IL-8, TNF-α), and oxidative stress (MDA, SOD) markers.
  • Confirmed molecular interactions using dual-luciferase reporter and RNA immunoprecipitation assays.

Main Results:

  • CircOSBPL2 expression was elevated in smokers and CSE-induced HBECs.
  • circOSBPL2 knockdown attenuated CSE-induced cell injury, apoptosis, inflammation, and oxidative stress.
  • circOSBPL2 acted as a sponge for miR-193a-5p, which directly targeted BRD4.
  • The circOSBPL2/miR-193a-5p/BRD4 axis mediated CSE-induced human bronchial epithelial cell injury.

Conclusions:

  • circOSBPL2 exacerbates apoptosis, inflammation, and oxidative stress in COPD via the miR-193a-5p/BRD4 pathway.
  • circOSBPL2 represents a novel insight into COPD pathogenesis.
  • circOSBPL2 inhibition offers a potential therapeutic strategy for COPD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.6K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
522